Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-011080
Filing Date
2025-05-15
Accepted
2025-05-15 17:22:58
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1073159
2 EX-31.1 ex31-1.htm EX-31.1 15143
3 EX-31.2 ex31-2.htm EX-31.2 15132
4 EX-32.1 ex32-1.htm EX-32.1 6349
5 EX-32.2 ex32-2.htm EX-32.2 6574
  Complete submission text file 0001641172-25-011080.txt   6349009

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ocea-20250331.xsd EX-101.SCH 54676
7 XBRL CALCULATION FILE ocea-20250331_cal.xml EX-101.CAL 44552
8 XBRL DEFINITION FILE ocea-20250331_def.xml EX-101.DEF 285307
9 XBRL LABEL FILE ocea-20250331_lab.xml EX-101.LAB 381959
10 XBRL PRESENTATION FILE ocea-20250331_pre.xml EX-101.PRE 332546
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1068202
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40793 | Film No.: 25955896
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)